Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

This study is the first investigation of intrahepatic T-VEC injection in patients with liver lesions due to metastatic solid tumors or hepatocellular carci

Read the full article here

Related Articles